Maintaining brain function and integrity is a pivotal part of anesthesiology practice and there is an increasing interest in the potential adverse cerebral effects of anesthesia and intensive care like postoperative cognitive decline1 and delirium.2 Despite this, brain monitoring is far from being a standard in anesthesia and critical care. The present overview aims to describe the current role of the 2 most frequently used monitoring methods for evaluation of brain function in the perioperative period, ie, electroencephalography (EEG) and brain oxygenation monitoring.
EEG-DERIVED BRAIN FUNCTION MONITORING
Various monitoring techniques have become available to monitor the functional activity of the brain. Investigators have focused mainly on the capability of several brain-monitoring techniques to measure the hypnotic and analgesic component of general anesthesia. Because the brain is the main target organ of general anesthesia and the EEG provides information on (spontaneous electrical) cortical activity, the information obtained by the EEG can be used as a surrogate measure of hypnosis.3,4 However, the EEG trace is complex and most clinicians are inexperienced encephalographers. Therefore, since the mid-1990s, a variety of EEG-derived indices has been introduced to aid the clinician in analyzing this information,5 with the bispectral index (BIS) as the most widely known and used index. EEG-derived indices are nowadays frequently used to improve perioperative anesthetic titration. Nevertheless, studies concerning the influence of EEG-derived indices on patient outcomes are inconclusive. This review aims to describe the available technologies for brain function monitoring and to detail their indications, comparability, and limitations.
The number of commercially available EEG-derived indices (measuring the hypnotic component) is still growing; using comparable principles, but especially differing regarding the algorithms used.6 These indices generally have a scaled index ranging between 100 and 0, where 100 represents “awake state” and 0 represents “no detectable brain electrical activity,” inversely correlated with the hypnotic drug concentration.7 The most commonly used and reviewed indices are the BIS (Medtronic, Boulder, CO), the E-Entropy (GE Healthcare, Helsinki, Finland), and the Narcotrend (Narcotrend Gruppe, Hannover, Germany), followed by the Patient State Index (SEDline, Masimo Corp, Irvine, CA) and the NeuroSense (WAV CNS, NeuroWave Systems Inc, Cleveland Heights, OH).
Monitoring techniques measuring the analgesic component of anesthesia, the balance between nociception and antinociception, is the most recent development in this field. Indices measuring this component are the qCON/qNOX (Quantium Medical, Barcelona, Spain),8 Composite Variability Index (Medtronic, Boulder, CO),9,10 and the Brain Anaesthesia Response monitor (Cortical Dynamics, North Perth, Australia).11 Consequently, an EEG-derived index can assist the clinician in guiding hypnotic and analgesic drug administration during anesthesia.
EEG-derived indices usually have only 2–4 electrodes placed on the forehead for receiving electrical signals from the (frontal) brain. The EEG signal is amplified, digitized, and filtered for analysis of the EEG trace.12 Most of the indices assume an underlying mathematical algorithm implying the relation between the electrical activity and the clinical state of arousal of the patient, with high and low frequencies corresponding with the awake state and deep hypnosis, respectively.4 These algorithms often use a multiparametric approach clustering the analysis of subparameters (eg, time domain, frequency domain, spectrum, and power analysis) of the EEG.13 Due to variations in algorithms used between indices, every device has their own specific intraoperative target range and absolute index values differ between various commercially available devices. Some indices use a proprietary-protected algorithm and are therefore not entirely published. The published specifications of the algorithms have been reviewed in detail elsewhere.6,14–20
As mentioned above, EEG-derived indices are mostly used to improve perioperative anesthetic drug titration, and most indices have been demonstrated to correlate closely with the hypnotic effect of most anesthetic drugs.21,22 However, convincing evidence on the influence of EEG-derived indices on patient outcomes is missing due to many confounding factors.23 Because BIS was the first and is the most widely used monitor, the vast majority of the clinical utility studies has been done with this index.7
The prevention of intraoperative awareness is regarded as one of the most important patient outcomes. Awareness is a rare event (1 case/19,600 patients),24 but could have really distressing consequences.25 Avidan and Mashour25 recently reviewed 6 large prospective trials studying the potential benefit of EEG-derived indices in preventing awareness. At first view, these trials gave inconsistent results; however, they concluded that the use of BIS could reduce intraoperative awareness in patients receiving total intravenous anesthesia, but when solely volatile agents are used, following an end-tidal anesthetic concentration titration protocol is as equally effective as a BIS-based protocol. These interpretations are in agreement with the recent conclusions of the Cochrane review concerning this topic.26
Significant cerebral ischemia or hypoperfusion during anesthesia can be detected by changes in the EEG. Particularly during stable anesthesia, a sudden alteration in the EEG (ie, shift in power to lower frequency ranges, decrease in amplitude [progressive], periods of burst suppression, or even isoelectricity) and/or a drop in the index value may indicate incidental cerebral ischemia.27,28 Nonetheless, a stable, unaltered BIS does not exclude ischemia in other parts of the brain than the frontal area.27,29 In all probability, other more specific monitors are more useful to detect cerebral ischemia and hypoperfusion,30 which will be discussed briefly later in this review.
The influence of index-guided anesthesia on drug consumption, emergence, and early recovery compared to routine care is an ongoing debate, with many studies showing an improvement in these outcomes,31–34 while others found no substantial effect.35–39 However, the authors of the latest Cochrane review26 concluded that, regardless of the hypnotic drug used, using the BIS could significantly reduce drug consumption, as well as all aspects of the postoperative recovery time. Only the length of hospital stay after ambulatory surgery is not significantly reduced.
Over the past decade, research suggested that deep anesthesia (BIS < 45) is correlated with postoperative mortality.40–45 Also a “triple low” state (a combination of low BIS, low blood pressure, and low minimum alveolar concentration), possibly related to anesthetic sensitivity, has been associated with a higher mortality rate.46 However, these associations are based on post hoc analyses.47
Until today, just 1 randomized controlled trial showed a significant association with deep anesthesia and mortality in high-risk patients,48 and 2 others failed to demonstrate this association.49,50 Therefore, an ongoing large prospective randomized controlled trial will further elucidate the influence of anesthetic depth on long-term mortality.51
A recent Cochrane review found that BIS is able to reduce the incidence of postoperative delirium compared to routine care.52 Evidence concerning the role of depth of anesthesia or even anesthesia in causing postoperative cognitive dysfunction (POCD) is still evolving, with conflicting results.1,53–58 Therefore, further research is needed.
Because there is no “gold standard” for measuring the depth of anesthesia, indirect parameters must be used to validate and compare EEG-derived indices.7 To accommodate comparisons between indices, the authors proposed a 5-step validation process to evaluate the different indices, consisting of the validation of the index for detecting clinical signs of anesthesia, pharmacokinetic-dynamic validation (quantifying the correlation between the index and the hypnotic drug concentration), validation of performance under clinical conditions, improving outcome, and a cost-effectiveness analysis. Until now, there is no convincing evidence for superiority of one of the indices over the other.6,7,18,59,60
The absolute values of EEG-derived indices have to be interpreted with caution because these indices suffer from a few limitations. The signal of the indices is influenced by a variety of variables other than changes in depth of anesthesia, including neurologic disorders such as dementia,61 muscle activity, electrical interference, and hypothermia.30,62 Moreover, the use of EEG-derived indices is not applicable for every hypnotic drug, such as ketamine and nitrous oxide, because it alters the raw EEG and power spectrum differently through its exertion on different molecular targets and neural pathways than most other hypnotic anesthetics.63–65 Because these drug-specific alterations are clearly visible in the raw EEG and power spectrum, it has been advocated to train the anesthesiologist in recognizing these real-time “signatures.”66,67 Supporting this opinion is the fact that the burst suppression pattern is readily visible in the raw EEG as well, while most indices have difficulties processing this pattern. In addition, the indices only monitor the frontal area of the brain, possibly missing valuable information on changing network relationships between brain regions during anesthesia.68,69 Furthermore, indices suffer from a time delay to calculate and display the index value and to process a sudden change in clinical state.70 It is therefore suggested not to change titration of anesthesia on absolute values rather than follow a trend analysis instead.
BRAIN OXYGENATION MONITORING
Taking a glance at the many tools available for monitoring of the cardiovascular system and comparing this number with the few commercially available systems for brain oxygenation monitoring, one may get the impression that brain integrity and function must be less important than that of heart and vessels. However, this discrepancy can easily be explained by the fact that the assessment of brain oxygenation is far from trivial and that—despite many years of clinical research—cerebral oxygenation monitoring is still an evolving field. This review aims to describe the commonly used technologies for brain oxygenation monitoring and to detail their indications, comparability, and limitations.
Jugular Bulb Venous Oxygen Saturation
Jugular bulb oxygen saturation (SjvO2) is reflective of the global ratio between cerebral oxygen delivery and demand. Technically, SjvO2 is derived from a catheter inserted in the jugular bulb by retrograde cannulation of the internal jugular vein. The positioning of the catheter may be facilitated by ultrasound; however, determination of the correct position in the jugular bulb needs to be performed radio- or angiographically due to the proximity of the facial vein which contributes oxygen-rich blood from extracranial tissue that may contaminate the measurements and lead to falsely high levels of SjvO2.71
Practically, determination of SjvO2 may be accomplished either by intermittent blood sampling or by use of a fiberoptic catheter. As described below, both methods may have relevant technical limitations that need to be taken into account. The technique was first described in humans around 1940 and was increasingly investigated up to the year 2000. However, since then, the scientific interest (expressed in published data on this topic according to PubMed) seems to have declined.
According to the Fick principle, the cerebral metabolic rate of oxygen (CMRO2) is equal to cerebral blood flow (CBF) times the difference between arterial and jugular venous oxygen content. Consequently, the ratio between arterial and jugular venous oxygen saturation reflects the balance between oxygen delivery and demand and may thus be used to indirectly determine CBF and CMRO2. Based on this, a low SjvO2may be reflective of a low oxygen delivery and/or CBF or a high CMRO2, and vice versa. Consequently, the interpretation of absolute values and trends of SjvO2needs to be made in the clinical context of the individual patient.71
With respect to the invasive nature of this monitoring modality, only sparse data on normal SjvO2values have been published, despite a variety of studies that used determination of SjvO2 in healthy volunteers for calibration purposes of cerebral oximeters (see below). The available studies give highly variable results for SjvO2 values (about 60.7% ± 3.6%), and especially for values in the lower range (with a lower limit [95% confidence interval] of 44.7 [36.5–53.0]%).72 SjvO2 levels below 55% have repeatedly been associated with poor neurological outcome.73 However, there is also evidence that—at least in patients with traumatic brain injury (TBI)—secondary brain damage occurs only if SjvO2 is below 45%.74
Comparably to direct brain tissue oxygenation, monitoring of SjvO2 has been, and continues to be used in patients with TBI to optimize cerebral oxygen delivery, frequently in combination with other monitoring modalities like intracranial pressure (ICP)/cerebral perfusion pressure (CPP) monitoring.75 Additionally, this variable has been used perioperatively in clinical situations during which evaluation of CMRO2 is necessary, ie, in patients undergoing major thoracic vascular surgery with deep hypothermic circulatory arrest.76
Clinical evidence from randomized trials supporting the use of SjvO2 for optimizing cerebral oxygen balance and guiding therapy for lowering increased ICP in neurocritical care is sparse. Consequently, current expert recommendations77 regarding the use of SjvO2 are mostly based on low quality of evidence with the exception of the statement, that “SjvO2-based therapy (using higher mean arterial blood pressure (MAP)/CPP and optimized volume management to augment CBF) does not improve outcome of severe TBI patients and therefore should not be used alone after TBI (high quality of evidence).” Despite this, the authors recommend that in “patients with severe TBI, abnormal SjvO2 and arterial and jugular venous oxygen content are useful physiological markers associated with poor prognosis (increased mortality, lower Glasgow outcome scale score) when used with other clinical and physiologic data (low quality of evidence).77
Similarly to the situation in neurocritical care, sparse data are available on the use of SjvO2 for guiding therapy in the perioperative setting. However, some lines of evidence suggest an association between low SjvO2 levels and an increased rate of POCD.78
Despite the concept of SjvO2 monitoring for assessing global cerebral oxygen balance and (indirectly) CBF seems to be straightforward and physiologically sound, this monitoring technology has some important limitations that not only question its clinical use, but also its fundamental role for calibrating cerebral oximeters (see below).
First, the assumption that cerebral venous effluent is bihemispherically comparable has been challenged. Almost 20 years ago, clinically relevant differences in SjvO2 in neurocritical care patients between the right and the left side have been shown.79 In 18% of patients, the difference was higher than 10%, and in 15% of patients even higher than 15% absolute. Moreover, some patients showed dynamic changes in SjvO2 leading to an even higher (more than 20%) difference, observations that clearly question the clinical usefulness of this monitoring.
As a second point, due to the proximity of the jugular bulb and the facial vein (draining relatively oxygen-rich extracranial blood into the jugular vein), even slightest deviations from the optimal catheter position may impair SjvO2 measurements. Taking into account interindividual variability in anatomy, it is on the one hand hard to imagine that it is always possible to position a catheter precisely based on a simple lateral head x-ray and on the other hand rather likely to assume that the catheter will always stay where it was positioned initially during the clinical care of a neurocritical patient.
Additionally, on intermittent blood sampling, contamination with blood from the facial vein may occur if blood is withdrawn too rapidly (faster than 2 mL/min).80 Likewise, if SjvO2 is measured continuously with a fiberoptic catheter, wall artifacts may lead to erroneous measurements.81
As a last but important point, as depicted above, mean normal ranges for SjvO2 have been reported to be in a range between 57.1% and 64.3% with a lower limit of 44.7%. This questions recent expert recommendations suggesting that a “SjvO2 <55% can be considered as the threshold for abnormality and to start intervention.”77
Cerebral Oxygen Saturation Determined by Near-Infrared Spectroscopy
Cerebral regional tissue oxygen saturation by near-infrared spectroscopy (NIRS) is the most recent development for bedside monitoring of brain oxygenation and increasingly used in various clinical settings.82 A growing number of cerebral oximeters is commercially available, using comparable principles, but differing regarding the technology of light emitters, sensors, wavelength, and the algorithms used. The information on brain oxygenation derived by this technology—thus the term regional cerebral (tissue) oxygen saturation ((rSc(t)O2 or simply ScO2)—is in between the strictly regional measurements of brain tissue PO2 and the global information derived from SjvO2. It reflects the regional oxygen balance and thus changes in regional blood flow and/or metabolism and is used to detect tissue hypoxia. It has to be noted that these regional changes may precede or occur independent of changes in global hemodynamics (lack of coherence between macro- and microcirculation).
The near-infrared range of the electromagnetic spectrum comprises wavelengths between 800 and 2500 nm and is located between the wavelengths of the visible and infrared light. The physical background is based on absorption analysis of light traveling through biological material according to the Beer-Lambert law. Near-infrared light is characterized by excellent tissue penetration (including bone tissue), allowing measurements of microvascular (<100 µm) hemoglobin oxygen saturation in deeper tissue layers (depending on the distance between light-emitting and light-receiving electrode), even through the skull. Whereas first versions used the transcranial illumination approach,83 current technology relies on reflection techniques, in which the near-infrared light travels in a banana-shaped arc from the emitting to the receiving diode. Most NIRS devices use spatial resolution by incorporating 2 receiving electrodes in a certain distance into their sensors, allowing to subtract signals coming from superficial (absorbance by skull and skin, detected by the shorter distance sensor) from those of deeper tissues (representing gray matter of the brain, assessed by the larger sensor distance), with a penetration depth of about 15 mm for the (larger) sensor distance of 40 mm.84 Another technique provides a tissue oxygen index (expressed in %) and concentration change in oxyhemoglobin by simultaneously integrating spatially resolved spectroscopy and the modified Beer-Lambert law. The spatially resolved spectroscopy technique is based on gathering the light signals at multiple closely spaced detectors. Because the depth of photon penetration is proportional to the source-detector distance, analyzing the differential signal as a function of this distance provides assessment of changes in oxygen saturation occurring in deep rather than superficial tissue layers.85,86
It has to be noted that NIRS measures the hemoglobin oxygen saturation within the microvessels (diameter <100 µm) and not the intracellular oxygenation (as the term tissue oxygenation erroneously implies). When calculating ScO2 values from absorption analysis, most devices assume a fixed ratio of the contribution of 20%–25% arterial and 75%–80% venous blood to the signal (neglecting the capillary blood volume of about 5%). This fixed ratio may however vary considerably between individuals, may be more influenced by arterial blood,87 and may depend on changes in body position (such as Trendelenburg or beach chair) or during hypoxia.88
Due to variations in the sensor technology and algorithms used, absolute ScO2 levels differ between various commercial devices and are not directly comparable.88 Based on data from volunteers undergoing tilting table maneuvers,89 as well as patients undergoing awake carotid endarterectomy,90,91 a decrease in relative ScO2 levels to more than 20% of baseline has been associated with a reduction in CBF severe enough to be accompanied by a loss of consciousness. Thus, it has been argued that the interpretation of ScO2 levels for most cerebral oximeters should not be based on absolute values rather than follow a trend analysis instead, ie, by interpreting the relative changes of ScO2 in relation to individual baseline values (before an intervention).
However, there is also evidence that absolute levels of ScO2 comprise clinically relevant information beyond cerebral oxygenation because pre- and perioperative ScO2 levels below a certain cutoff level (usually 50%–60%) have been associated with an increase in neurological and/or general complications and increased mortality.92–94 As exemplified in the Figure, pronounced cerebral desaturations or bihemispherical differences in ScO2 might indicate inadequately perfused brain tissue at risk of cerebral infarction and initiate further postoperative diagnostics. Observational studies have shown associations between ScO2 and a variety of demographic, anamnestic, and cardiovascular risk variables including age, body mass index, hematocrit, and left ventricular ejection fraction. Moreover, clinically relevant associations between humoral cardiopulmonary function markers like high-sensitive troponin T and the N-terminal prohormone of B-type natriuretic peptide have been observed in patients scheduled for cardiac surgery.92 These findings clearly support the notion that absolute levels of ScO2 do indeed provide useful information, but also point to a clinically relevant influence of systemic factors (perfusion and oxygen balance) on ScO2.
In line with this, the normal range of ScO2 in healthy volunteers has been reported to be around 70% ± 6% (range, 58%–82%),102 while patients with cardiovascular disease scheduled for cardiac surgery frequently present with lower ScO2 baseline levels of about 65% ± 9% with a typical range between 47% and 83%.89,103,104 Assuming typical average values for oxygen saturation of the arterial blood of 97% and a SjvO2 of 60.7% and an arterial to venous blood ratio of 25/75 contributing to the signal (see above), we can calculate a normal ScO2 levels of about 69.8% (97% × 0.25 + 60.7% × 0.75),105 which is close to the values found in healthy volunteers. Given a standard deviation of 6%, this implies that ScO2 levels below 58% (69.8% − 1.96 × 6%) represent cerebral ischemia or hypoxia, while ScO2 levels above 81.5% (69.8% + 1.96 × 6%) in general indicates an adequate (frontal) cerebral perfusion. Of note, high ScO2 values can also indicate hyperperfusion (as seen with hypercapnia). Absolute ScO2 values between 58% and 81.5% thus represent the gray zone of inconclusive values, where its diagnostic ability is limited and should not lead to therapeutic interventions.105 Yet, this range will include most of the clinical measurements, and coincidentally represents the normal range of ScO2 in healthy volunteers (see above).
In contrast to the aforementioned technologies for brain oxygenation, after introduction in clinical practice, cerebral oximetry was predominantly used outside neuroanesthesia and neurocritical care in patients undergoing cardiovascular surgery with a high risk of compromised cerebral perfusion, ie, in cardiac and carotid surgery.82 However, within the last years, the use of cerebral oximetry has broadened and the technology is now increasingly used in other clinical settings like in high-risk noncardiac surgery,106 in patients undergoing anesthesia in the beach chair position (eg, for shoulder surgery),107–115 in patients with stroke undergoing thrombectomy,116,117 during extracorporeal life support and membrane oxygenation,118,119 in the intensive care unit120 and during cardiopulmonary resuscitation,106,121–132 just to name a few.
Despite these developments, scientific evidence on the effects of cerebral oximetry on clinical outcomes is controversial. The most recent systematic review—focusing on the prevention of neurological complications in cardiac surgical patients—neither found conclusive evidence that a decrease in cerebral oxygen saturation was associated with an increased rate of neurological complications (delirium/POCD/stroke) nor that a therapy aiming to avoid cerebral desaturation prevented any of these complications.133 In contrast, taking into account also systemic complications and including more recent findings from the cardiovascular field (Table 1) and studies on patients undergoing other types of surgery as well (Table 2), a completely different picture arises: not only that a majority of study results clearly supports that there is indeed an association between a perioperatively decreased ScO2 and an increased complication rate94,120,134–136,138–140,144,147,149–153 but there is also a majority of studies showing that a goal-directed therapy aiming to avoid cerebral desaturations is effective in terms of a reduction in cerebral and/or systemic complications (Tables 1 and 2).134,137,141–143,148 The latter approach has been challenged by 2 recent multicenter trials (1 being primarily a feasibility study) and a systematic review that failed to show significant effects of interventions or algorithms to prevent or restore a perioperatively decreased ScO2.145,146,154
Currently there are no formal guidelines on the use of cerebral oximetry in cardiovascular surgery available. However, there is consensus to use this technology in patients undergoing aortic arch surgery and in the pediatric cardiac surgical population, and maybe also in patients with history of hypertension, carotid stenosis, or cerebral ischemia.
As stated above, the cerebral oximetry signal is influenced by a variety of variables reflecting systemic perfusion, probably due to the fact that the signal is—at least partially—“contaminated” by extracranial perfusion.155–160 For example, despite still a little bit controversial with respect to the confounding influence of cerebral autoregulation,145 some studies clearly show that the application of vasopressors affects NIRS-derived ScO2, whereas invasively derived cerebral oxygenation remains unchanged.161,162 Moreover, extracranial contamination may—at least in part—explain the association between preoperative ScO2 and clinical outcomes in the cardiac surgical population,92 as well as the correlation of ScO2 with mixed venous oxygen saturation.163
Another limitation refers to the fact that—as described above—all cerebral oximeters are calibrated assuming a fixed ratio between arterial and venous blood in the brain, based on the direct measurements of arterial and venous saturations.105 Consequently, all limitations ascribed to the precision of SjvO2—measurements apply also to the calibration process of these devices; and besides sensor technology and wavelengths used, this may explain some of the variability observed between available cerebral oximeters from different manufacturers.88
Comparability of Brain Oxygenation Measurements With Different Technologies.
As discussed above, only few technologies for monitoring oxygen in the brain in the clinical setting are available, and—despite technical advancements—we are still far from having a clinical gold standard to universally accomplish this goal. And it remains highly questionable if such a “gold standard” will be developed within the foreseeable future.
Taking into account the clinically available technologies, the spectrum reaches from highly invasive probes monitoring oxygen tension in an extremely small area of brain tissue (not discussed within this review article) to the truly noninvasive technology of NIRS—with the limitation of being influenced by extracranial contamination, but being capable of interrogation of a broader area of the vulnerable boarder zone of frontal brain tissue—further to the evaluation of global brain oxygen balance by SjvO2. The latter again being influenced by anatomic factors difficult to estimate and, comparably to NIRS-derived oxygenation, by systemic perfusion. Consequently, it is not astonishing that comparison studies failed to show comparability between the different monitoring modalities.164,165
However, from a clinical point of view, if no gold standard is available, it seems reasonable—if any—to choose the monitoring modality for which improvements in outcomes have most consistently been demonstrated. At present, this does only apply to the use of cerebral oximetry in patients undergoing cardiac surgery.
Autoregulation of CBF
Autoregulation of blood flow is a key feature of the human cerebral vasculature to guarantee adequate oxygenation of the brain under changing physiological conditions.166 This is essential because, due to its high metabolic activity, the brain does not tolerate hypoxia or hypoperfusion. The autoregulation of CBF provides a steady flow of blood toward the brain by altering vascular resistance through complex myogenic, neurogenic, and metabolic mechanisms. This autoregulatory control mechanism therefore buffers any variations in MAP and CPP and is effective in a MAP range between approximately 50 and 150 mm Hg, defining the lower limit of autoregulation (LLA) and upper limit of autoregulation, respectively. This range of intact autoregulation may, however, vary considerably between individuals, and shifts to higher thresholds have been observed in elderly and hypertensive patients. At the blood pressure extremes, ie, below the LLA and above the upper limit of autoregulation, the cerebral vasculature is no longer able to adapt its resistance in response to further blood pressure changes. The clinical consequence is that, for instance, intraoperative hypotension (ie, MAP values below the LLA) will be poorly tolerated, and might cause ischemic events and postoperative neurological complications, as well as dysfunction of other pressure-dependent organs like the kidneys.166 Interestingly, recent evidence from observational trials is clearly supporting this concept.
Assuming that ScO2 is a reliable surrogate of CBF, it has been shown that—based on continuous correlation analyses between ScO2 and MAP and calculation of a cerebral oximetry index—the individual LLA can be determined at the bedside and in the operating room167 and that perfusion below the LLA is associated with postoperative morbidity,168 as well as increased expression of a biomarker of neurological damage.169 Furthermore, assessment of cerebral autoregulation has been used to explain paradoxical changes in ScO2 induced by vasoactive medication, which was found exclusively in patients with intact cerebral autoregulation.170
A recent meta-analysis including 33 studies and 3059 patients confirmed that cerebral autoregulation monitoring could predict mortality in patients with traumatic brain injury and with subarachnoid hemorrhage, and that continuous assessment of cerebral autoregulation predicted outcome better than intermittent monitoring.171
There is increasing evidence that the use of brain function monitoring by processed EEG and brain oxygenation monitoring by NIRS are useful adjuncts for improving patient care in the perioperative period.
EEG-derived parameters may be especially helpful for optimizing anesthetic titration to avoid unwarranted effects of inappropriately deep anesthesia and promoting fast postoperative recovery.
The invasive technologies of direct brain tissue oxygen monitoring and jugular venous oxygen saturation monitoring—despite of debatable reliability—may be helpful in selected patients undergoing anesthesia and intensive care treatment for neurological disorders, but hardly play a role outside neurocritical care.
In contrast, increasing evidence suggests that avoiding a mismatch between brain oxygen delivery and demand by goal-directed optimization of NIRS-derived cerebral oxygen saturation leads to a reduction of neurological and/or general perioperative complications. Recent evidence points out that this technology may be additionally used to assess autoregulation of CBF and thereby help to titrate arterial blood pressure to the individual needs and for bedside diagnosis of disturbed autoregulation.
Name: Thomas W. L. Scheeren, MD, PhD.
Contribution: This author helped write the manuscript.
Conflicts of Interest: T. W. L. Scheeren’s research group received honoraria from Masimo Inc and from Edwards Lifesciences (both at Irvine, CA) for consulting and lecturing. Thomas W. L. Scheeren is the chair of the Scientific Subcommittee 14 (Monitoring, Equipment, and Ultrasound) of the European Society of Anaesthesiologists and associate editor of the Journal of Clinical Monitoring and Computing.
Name: Merel H. Kuizenga, MD.
Contribution: This author helped write and edit the manuscript.
Conflicts of Interest: None.
Name: Holger Maurer, MD.
Contribution: This author helped prepare the table.
Conflicts of Interest: H. Maurer received honoraria for lecturing from CSL Behring (Marburg, Germany).
Name: Michel M. R. F. Struys, MD, PhD.
Contribution: This author helped write the manuscript.
Conflicts of Interest: M. M. R. F. Struys’s research group and department received grants and funding from The Medicines Company (Parsippany, NJ), Masimo (Irvine, CA), Fresenius (Bad Homburg, Germany), Acacia Design (Maastricht, the Netherlands), Medtronic (Dublin, Ireland); and honoraria from The Medicines Company (Parsippany, NJ), Masimo (Irvine, CA), Fresenius (Bad Homburg, Germany), Baxter (Deerfield, IL), Medtronic (Dublin, Ireland), Demed Medical (Temse, Belgium). In addition, M. M. R. F. Struys is an editorial board member of the British Journal of Anaesthesia and a senior editor of Anesthesia & Analgesia.
Name: Matthias Heringlake, MD.
Contribution: This author helped write the manuscript.
Conflicts of Interest: M. Heringlake received honoraria for consulting and lecturing from Medtronic-Covidien (Minneapolis, MN), Orion Pharma (Espoo, Finland), Amomed Pharma (Vienna, Austria), Tenax Therapeutics (Morrisville, NC), Fresenius Medical (Bad Homburg, Germany), and Baxter Medical (Unterschleissheim, Germany).
This manuscript was handled by: Maxime Cannesson, MD, PhD.
1. Patel D, Lunn AD, Smith AD, Lehmann DJ, Dorrington KL. Cognitive decline in the elderly after surgery and anaesthesia: results from the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Anaesthesia. 2016;71:1144–1152.
2. Monk TG, Price CC. Postoperative cognitive disorders. Curr Opin Crit Care. 2011;17:376–381.
3. Shoushtarian M, Sahinovic MM, Absalom AR. Comparisons of electroencephalographically derived measures of hypnosis and antinociception in response to standardized stimuli during target-controlled propofol-remifentanil anesthesia. Anesth Analg. 2016;122:382–392.
4. Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology. 1998;89:980–1002.
5. Shander A, Lobel GP, Mathews DM. Brain monitoring and the depth of anesthesia: another goldilocks dilemma. Anesth Analg. 2018;126:705–709.
6. Marchant N, Sanders R, Sleigh J. How electroencephalography serves the anesthesiologist. Clin EEG Neurosci. 2014;45:22–32.
7. Heyse B, Van Ooteghem B, Wyler B, Struys MM, Herregods L, Vereecke H. Comparison of contemporary EEG derived depth of anesthesia monitors with a 5 step validation process. Acta Anaesthesiol Belg. 2009;60:19–33.
8. Jensen EW, Valencia JF, López A. Monitoring hypnotic effect and nociception with two EEG-derived indices, qCON and qNOX, during general anaesthesia. Acta Anaesthesiol Scand. 2014;58:933–941.
9. Ellerkmann RK, Grass A, Hoeft A, Soehle M. The response of the composite variability index to a standardized noxious stimulus during propofol-remifentanil anesthesia. Anesth Analg. 2013;116:580–588.
10. Sahinovic MM, Eleveld DJ, Kalmar AF. Accuracy of the composite variability index as a measure of the balance between nociception and antinociception during anesthesia. Anesth Analg. 2014;119:288–301.
11. Shoushtarian M, McGlade DP, Delacretaz LJ, Liley DT. Evaluation of the brain anaesthesia response monitor during anaesthesia for cardiac surgery: a double-blind, randomised controlled trial using two doses of fentanyl. J Clin Monit Comput. 2016;30:833–844.
12. Hajat Z, Ahmad N, Andrzejowski J. The role and limitations of EEG-based depth of anaesthesia monitoring in theatres and intensive care. Anaesthesia. 2017;72suppl 138–47.
13. Fahy BG, Chau DF. The technology of processed electroencephalogram monitoring devices for assessment of depth of anesthesia. Anesth Analg. 2018;126:111–117.
14. Johansen JW. Update on bispectral index monitoring. Best Pract Res Clin Anaesthesiol. 2006;20:81–99.
15. Bein B. Entropy. Best Pract Res Clin Anaesthesiol. 2006;20:101–109.
16. Kreuer S, Wilhelm W. The Narcotrend monitor. Best Pract Res Clin Anaesthesiol. 2006;20:111–119.
17. Drover D, Ortega HR. Patient state index. Best Pract Res Clin Anaesthesiol. 2006;20:121–128.
18. Vanluchene AL, Vereecke H, Thas O, Mortier EP, Shafer SL, Struys MM. Spectral entropy as an electroencephalographic measure of anesthetic drug effect: a comparison with bispectral index and processed midlatency auditory evoked response. Anesthesiology. 2004;101:34–42.
19. Bresson J, Gayat E, Agrawal G. A randomized controlled trial comparison of NeuroSENSE and bispectral brain monitors during propofol-based versus sevoflurane-based general anesthesia. Anesth Analg. 2015;121:1194–1201.
20. Bibian S, Dumont GA, Zikov T. Dynamic behavior of BIS, M-entropy and neuroSENSE brain function monitors. J Clin Monit Comput. 2011;25:81–87.
21. Bruhn J, Bouillon TW, Radulescu L, Hoeft A, Bertaccini E, Shafer SL. Correlation of approximate entropy, bispectral index, and spectral edge frequency 95 (SEF95) with clinical signs of “anesthetic depth” during coadministration of propofol and remifentanil. Anesthesiology. 2003;98:621–627.
22. Bruhn J, Myles PS, Sneyd R, Struys MM. Depth of anaesthesia monitoring: what’s available, what’s validated and what’s next? Br J Anaesth. 2006;97:85–94.
23. Escallier KE, Nadelson MR, Zhou D, Avidan MS. Monitoring the brain: processed electroencephalogram and peri-operative outcomes. Anaesthesia. 2014;69:899–910.
24. Pandit JJ, Andrade J, Bogod DG, et al. Royal College of Anaesthetists; Association of Anaesthetists of Great Britain and Ireland. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Br J Anaesth. 2014;113:549–559.
25. Avidan MS, Mashour GA. Prevention of intraoperative awareness with explicit recall: making sense of the evidence. Anesthesiology. 2013;118:449–456.
26. Punjasawadwong Y, Phongchiewboon A, Bunchungmongkol N. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev. 2014;6:CD003843.
27. Billard V. Brain injury under general anesthesia: is monitoring of the EEG helpful? Can J Anaesth. 2001;48:1055–1060.
28. Mérat S, Lévecque JP, Le Gulluche Y, Diraison Y, Brinquin L, Hoffmann JJ. BIS monitoring may allow the detection of severe cerebral ischemia. Can J Anaesth. 2001;48:1066–1069.
29. Morimoto Y, Monden Y, Ohtake K, Sakabe T, Hagihira S. The detection of cerebral hypoperfusion with bispectral index monitoring during general anesthesia. Anesth Analg. 2005;100:158–161.
30. Kertai MD, Whitlock EL, Avidan MS. Brain monitoring with electroencephalography and the electroencephalogram-derived bispectral index during cardiac surgery. Anesth Analg. 2012;114:533–546.
31. Gan TJ, Glass PS, Windsor A, et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group. Anesthesiology. 1997;87:808–815.
32. Kreuer S, Biedler A, Larsen R, Altmann S, Wilhelm W. Narcotrend monitoring allows faster emergence and a reduction of drug consumption in propofol-remifentanil anesthesia. Anesthesiology. 2003;99:34–41.
33. Boztuğ N, Bigat Z, Akyuz M, Demir S, Ertok E. Does using the bispectral index (BIS) during craniotomy affect the quality of recovery? J Neurosurg Anesthesiol. 2006;18:1–4.
34. Chiu CL, Ong G, Majid AA. Impact of bispectral index monitoring on propofol administration in patients undergoing cardiopulmonary bypass. Anaesth Intensive Care. 2007;35:342–347.
35. Pavlin JD, Souter KJ, Hong JY, Freund PR, Bowdle TA, Bower JO. Effects of bispectral index monitoring on recovery from surgical anesthesia in 1,580 inpatients from an academic medical center. Anesthesiology. 2005;102:566–573.
36. Bruhn J, Kreuer S, Bischoff P. Bispectral index and A-line AAI index as guidance for desflurane-remifentanil anaesthesia compared with a standard practice group: a multicentre study. Br J Anaesth. 2005;94:63–69.
37. Kreuer S, Bruhn J, Stracke C. Narcotrend or bispectral index monitoring during desflurane-remifentanil anesthesia: a comparison with a standard practice protocol. Anesth Analg. 2005;101:427–434.
38. Zohar E, Luban I, White PF, Ramati E, Shabat S, Fredman B. Bispectral index monitoring does not improve early recovery of geriatric outpatients undergoing brief surgical procedures. Can J Anaesth. 2006;53:20–25.
39. Luginbühl M, Wüthrich S, Petersen-Felix S, Zbinden AM, Schnider TW. Different benefit of bispectal index (BIS) in desflurane and propofol anesthesia. Acta Anaesthesiol Scand. 2003;47:165–173.
40. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005;100:4–10.
41. Lindholm ML, Träff S, Granath F. Mortality within 2 years after surgery in relation to low intraoperative bispectral index values and preexisting malignant disease. Anesth Analg. 2009;108:508–512.
42. Leslie K, Myles PS, Forbes A, Chan MT. The effect of bispectral index monitoring on long-term survival in the B-aware trial. Anesth Analg. 2010;110:816–822.
43. Kertai MD, Pal N, Palanca BJ, et al. B-Unaware Study Group. Association of perioperative risk factors and cumulative duration of low bispectral index with intermediate-term mortality after cardiac surgery in the B-Unaware Trial. Anesthesiology. 2010;112:1116–1127.
44. Kertai MD, Palanca BJ, Pal N, et al. B-Unaware Study Group. Bispectral index monitoring, duration of bispectral index below 45, patient risk factors, and intermediate-term mortality after noncardiac surgery in the B-Unaware Trial. Anesthesiology. 2011;114:545–556.
45. Zorrilla-Vaca A, Healy RJ, Wu CL, Grant MC. Relation between bispectral index measurements of anesthetic depth and postoperative mortality: a meta-analysis of observational studies. Can J Anaesth. 2017;64:597–607.
46. Sessler DI, Sigl JC, Kelley SD. Hospital stay and mortality are increased in patients having a “triple low” of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia. Anesthesiology. 2012;116:1195–1203.
47. Leslie K, Short TG. Anesthetic depth and long-term survival: an update. Can J Anaesth. 2016;63:233–240.
48. Abdelmalak BB, Bonilla A, Mascha EJ. Dexamethasone, light anaesthesia, and tight glucose control (DeLiT) randomized controlled trial. Br J Anaesth. 2013;111:209–221.
49. Brown CH 4th, Azman AS, Gottschalk A, Mears SC, Sieber FE. Sedation depth during spinal anesthesia and survival in elderly patients undergoing hip fracture repair. Anesth Analg. 2014;118:977–980.
50. Short TG, Leslie K, Campbell D. A pilot study for a prospective, randomized, double-blind trial of the influence of anesthetic depth on long-term outcome. Anesth Analg. 2014;118:981–986.
51. Short TG, Leslie K, Chan MT, Campbell D, Frampton C, Myles P. Rationale and design of the balanced anesthesia study: a prospective randomized clinical trial of two levels of anesthetic depth on patient outcome after major surgery. Anesth Analg. 2015;121:357–365.
52. Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016;3:CD005563.
53. Dokkedal U, Hansen TG, Rasmussen LS, Mengel-From J, Christensen K. Cognitive functioning after surgery in middle-aged and elderly Danish twins. Anesthesiology. 2016;124:312–321.
54. Farag E, Chelune GJ, Schubert A, Mascha EJ. Is depth of anesthesia, as assessed by the bispectral index, related to postoperative cognitive dysfunction and recovery? Anesth Analg. 2006;103:633–640.
55. Steinmetz J, Funder KS, Dahl BT, Rasmussen LS. Depth of anaesthesia and post-operative cognitive dysfunction. Acta Anaesthesiol Scand. 2010;54:162–168.
56. Ballard C, Jones E, Gauge N. Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One. 2012;7:e37410.
57. Chan MT, Cheng BC, Lee TM, Gin T. CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013;25:33–42.
58. Radtke FM, Franck M, Lendner J, Krüger S, Wernecke KD, Spies CD. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth. 2013;110suppl 1i98–i105.
59. Shepherd J, Jones J, Frampton G, Bryant J, Baxter L, Cooper K. Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation. Health Technol Assess. 2013;17:1–264.
60. National Institute for Clinical Excellence. Depth of Anaesthesia Monitors—Bispectral index (BIS), E-Entropy and Narcotrend Compact M. Available at: www.nice.org.uk/guidance/dg6
. Accessed February 2017.
61. Renna M, Handy J, Shah A. Low baseline bispectral index of the electroencephalogram in patients with dementia. Anesth Analg. 2003;96:1380–1385.
62. Pandit JJ, Cook TM. National Institute for Clinical Excellence guidance on measuring depth of anaesthesia: limitations of EEG-based technology. Br J Anaesth. 2013;110:325–328.
63. Vereecke HE, Struys MM, Mortier EP. A comparison of bispectral index and ARX-derived auditory evoked potential index in measuring the clinical interaction between ketamine and propofol anaesthesia. Anaesthesia. 2003;58:957–961.
64. Hans P, Dewandre PY, Brichant JF, Bonhomme V. Comparative effects of ketamine on Bispectral Index and spectral entropy of the electroencephalogram under sevoflurane anaesthesia. Br J Anaesth. 2005;94:336–340.
65. Hirota K. Special cases: ketamine, nitrous oxide and xenon. Best Pract Res Clin Anaesthesiol. 2006;20:69–79.
66. Purdon PL, Sampson A, Pavone KJ, Brown EN. Clinical electroencephalography for anesthesiologists: part I: background and basic signatures. Anesthesiology. 2015;123:937–960.
67. Purdon PL, Pierce ET, Mukamel EA, et al. Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proc Natl Acad Sci USA. 2013;110:E1142–E1151.
68. Lee U, Oh G, Kim S, Noh G, Choi B, Mashour GA. Brain networks maintain a scale-free organization across consciousness, anesthesia, and recovery: evidence for adaptive reconfiguration. Anesthesiology. 2010;113:1081–1091.
69. Mashour GA, Orser BA, Avidan MS. Intraoperative awareness: from neurobiology to clinical practice. Anesthesiology. 2011;114:1218–1233.
70. Zanner R, Pilge S, Kochs EF, Kreuzer M, Schneider G. Time delay of electroencephalogram index calculation: analysis of cerebral state, bispectral, and Narcotrend indices using perioperatively recorded electroencephalographic signals. Br J Anaesth. 2009;103:394–399.
71. Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. Br J Anaesth. 2006;97:26–38.
72. Chieregato A, Calzolari F, Trasforini G, Targa L, Latronico N. Normal jugular bulb oxygen saturation. J Neurol Neurosurg Psychiatry. 2003;74:784–786.
73. Roh D, Park S. Brain multimodality monitoring: updated perspectives. Curr Neurol Neurosci Rep. 2016;16:56.
74. Chan MT, Ng SC, Lam JM, Poon WS, Gin T. Re-defining the ischemic threshold for jugular venous oxygen saturation–a microdialysis study in patients with severe head injury. Acta Neurochir Suppl. 2005;95:63–66.
75. Stover JF. Contemporary view on neuromonitoring following severe traumatic brain injury. World J Crit Care Med. 2012;1:15–22.
76. Tsaousi GG, Pitsis AA, Deliaslani DV, Amaniti EN, Karakoulas KA, Vasilakos DG. Cerebral oxygenation impairment and S-100β protein release during off-pump coronary artery revascularization. J Cardiothorac Vasc Anesth. 2013;27:245–252.
77. Le Roux P, Menon DK, Citerio G, et al. The International Multidisciplinary Consensus Conference on multimodality monitoring in neurocritical care: a list of recommendations and additional conclusions: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Neurocrit Care. 2014;21suppl 2S282–S296.
78. Kadoi Y, Saito S, Goto F, Fujita N. Decrease in jugular venous oxygen saturation during normothermic cardiopulmonary bypass predicts short-term postoperative neurologic dysfunction in elderly patients. J Am Coll Cardiol. 2001;38:1450–1455.
79. Stocchetti N, Magnoni S, Zanier ER. My paper 20 years later: cerebral venous oxygen saturation studied with bilateral samples in the internal jugular veins. Intensive Care Med. 2015;41:412–417.
80. Matta BF, Lam AM. The rate of blood withdrawal affects the accuracy of jugular venous bulb. Oxygen saturation measurements. Anesthesiology. 1997;86:806–808.
81. Anastasiou E, Gerolioliou K, Karakoulas K, Peftoulidou M, Giala M. Reliability of continuous jugular venous bulb hemoglobin oxygen saturation during cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13:276–279.
82. Scheeren TW, Schober P, Schwarte LA. Monitoring tissue oxygenation by near infrared spectroscopy (NIRS): background and current applications. J Clin Monit Comput. 2012;26:279–287.
83. Jöbsis FF. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science. 1977;198:1264–1267.
84. Patil AV, Safaie J, Moghaddam HA, Wallois F, Grebe R. Experimental investigation of NIRS spatial sensitivity. Biomed Opt Express. 2011;2:1478–1493.
85. Steenhaut K, Lapage K, Bové T, De Hert S, Moerman A. Evaluation of different near-infrared spectroscopy technologies for assessment of tissue oxygen saturation during a vascular occlusion test. J Clin Monit Comput. 2017;31:1151–1158.
86. Messere A, Roatta S. Influence of cutaneous and muscular circulation on spatially resolved versus standard Beer-Lambert near-infrared spectroscopy. Physiol Rep. 2013;1:e00179.
87. Sørensen H, Secher NH, Rasmussen P. A note on arterial to venous oxygen saturation as reference for NIRS-determined frontal lobe oxygen saturation in healthy humans. Front Physiol. 2013;4:403.
88. Bickler PE, Feiner JR, Rollins MD. Factors affecting the performance of 5 cerebral oximeters during hypoxia in healthy volunteers. Anesth Analg. 2013;117:813–823.
89. Edmonds HL Jr, Ganzel BL, Austin EH 3rd.. Cerebral oximetry for cardiac and vascular surgery. Semin Cardiothorac Vasc Anesth. 2004;8:147–166.
90. Moritz S, Kasprzak P, Arlt M, Taeger K, Metz C. Accuracy of cerebral monitoring in detecting cerebral ischemia during carotid endarterectomy: a comparison of transcranial Doppler sonography, near-infrared spectroscopy, stump pressure, and somatosensory evoked potentials. Anesthesiology. 2007;107:563–569.
91. Samra SK, Dy EA, Welch K, Dorje P, Zelenock GB, Stanley JC. Evaluation of a cerebral oximeter as a monitor of cerebral ischemia during carotid endarterectomy. Anesthesiology. 2000;93:964–970.
92. Heringlake M, Garbers C, Käbler JH. Preoperative cerebral oxygen saturation and clinical outcomes in cardiac surgery. Anesthesiology. 2011;114:58–69.
93. Sun X, Ellis J, Corso PJ. Mortality predicted by preinduction cerebral oxygen saturation after cardiac operation. Ann Thorac Surg. 2014;98:91–96.
94. Schoen J, Meyerrose J, Paarmann H, Heringlake M, Hueppe M, Berger KU. Preoperative regional cerebral oxygen saturation is a predictor of postoperative delirium in on-pump cardiac surgery patients: a prospective observational trial. Crit Care. 2011;15:R218.
95. Reents W, Muellges W, Franke D, Babin-Ebell J, Elert O. Cerebral oxygen saturation assessed by near-infrared spectroscopy during coronary artery bypass grafting and early postoperative cognitive function. Ann Thorac Surg. 2002;74:109–114.
96. Negargar S, Mahmoudpour A, Taheri R, Sanaie S. The relationship between cerebral oxygen saturation changes and post operative neurologic complications in patients undergoing cardiac surgery. Pak J Med Sci. 2007;23:380–385.
97. Hong SW, Shim JK, Choi YS, Kim DH, Chang BC, Kwak YL. Prediction of cognitive dysfunction and patients’ outcome following valvular heart surgery and the role of cerebral oximetry. Eur J Cardiothorac Surg. 2008;33:560–565.
98. Schön J, Serien V, Hanke T, et al. Cerebral oxygen saturation monitoring in on-pump cardiac surgery – A 1 year experience. Appl Cardiopulm Pathophysiol. 2009;13:243–252.
99. Salazar D, Sears BW, Aghdasi B. Cerebral desaturation events during shoulder arthroscopy in the beach chair position: patient risk factors and neurocognitive effects. J Shoulder Elbow Surg. 2013;22:1228–1235.
100. Trafidło T, Gaszyński T, Gaszyński W, Nowakowska-Domagała K. Intraoperative monitoring of cerebral NIRS oximetry leads to better postoperative cognitive performance: a pilot study. Int J Surg. 2015;16:23–30.
101. Meng L, Xiao J, Gudelunas K, Yu Z, Zhong Z, Hu X. Association of intraoperative cerebral and muscular tissue oxygen saturation with postoperative complications and length of hospital stay after major spine surgery: an observational study. Br J Anaesth. 2017;118:551–562.
102. Kim MB, Ward DS, Cartwright CR, Kolano J, Chlebowski S, Henson LC. Estimation of jugular venous O2
saturation from cerebral oximetry or arterial O2
saturation during isocapnic hypoxia. J Clin Monit Comput. 2000;16:191–199.
103. Chan MJ, Chung T, Glassford NJ, Bellomo R. Near-infrared spectroscopy in adult cardiac surgery patients: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2017;31:1155–1165.
104. Subramanian B, Nyman C, Fritock M. A multicenter pilot study assessing regional cerebral oxygen desaturation frequency during cardiopulmonary bypass and responsiveness to an intervention algorithm. Anesth Analg. 2016;122:1786–1793.
105. Scheeren TW. Journal of Clinical Monitoring and Computing 2015 end of year summary: tissue oxygenation and microcirculation. J Clin Monit Comput. 2016;30:141–146.
106. Green DW, Kunst G. Cerebral oximetry and its role in adult cardiac, non-cardiac surgery and resuscitation from cardiac arrest. Anaesthesia. 2017;72suppl 148–57.
107. Closhen D, Berres M, Werner C, Engelhard K, Schramm P. Influence of beach chair position on cerebral oxygen saturation: a comparison of INVOS and FORE-SIGHT cerebral oximeter. J Neurosurg Anesthesiol. 2013;25:414–419.
108. Tange K, Kinoshita H, Minonishi T. Cerebral oxygenation in the beach chair position before and during general anesthesia. Minerva Anestesiol. 2010;76:485–490.
109. Picton P, Dering A, Alexander A. Influence of ventilation strategies and anesthetic techniques on regional cerebral oximetry in the beach chair position: a prospective interventional study with a randomized comparison of two anesthetics. Anesthesiology. 2015;123:765–774.
110. Murphy GS, Szokol JW, Marymont JH. Cerebral oxygen desaturation events assessed by near-infrared spectroscopy during shoulder arthroscopy in the beach chair and lateral decubitus positions. Anesth Analg. 2010;111:496–505.
111. Mori Y, Yamada M, Akahori T. Cerebral oxygenation in the beach chair position before and during general anesthesia in patients with and without cardiovascular risk factors. J Clin Anesth. 2015;27:457–462.
112. Moerman AT, De Hert SG, Jacobs TF, De Wilde LF, Wouters PF. Cerebral oxygen desaturation during beach chair position. Eur J Anaesthesiol. 2012;29:82–87.
113. Meex I, Vundelinckx J, Buyse K. Cerebral tissue oxygen saturation values in volunteers and patients in the lateral decubitus and beach chair positions: a prospective observational study. Can J Anaesth. 2016;63:537–543.
114. Jeong H, Jeong S, Lim HJ, Lee J, Yoo KY. Cerebral oxygen saturation measured by near-infrared spectroscopy and jugular venous bulb oxygen saturation during arthroscopic shoulder surgery in beach chair position under sevoflurane-nitrous oxide or propofol-remifentanil anesthesia. Anesthesiology. 2012;116:1047–1056.
115. Cho SY, Kim SJ, Jeong CW. Under general anesthesia arginine vasopressin prevents hypotension but impairs cerebral oxygenation during arthroscopic shoulder surgery in the beach chair position. Anesth Analg. 2013;117:1436–1443.
116. Hametner C, Stanarcevic P, Stampfl S, Rohde S, Veltkamp R, Bösel J. Noninvasive cerebral oximetry during endovascular therapy for acute ischemic stroke: an observational study. J Cereb Blood Flow Metab. 2015;35:1722–1728.
117. Ritzenthaler T, Cho TH, Luis D, Berthezene Y, Nighoghossian N. Usefulness of near-infrared spectroscopy in thrombectomy monitoring. J Clin Monit Comput. 2015;29:585–589.
118. Wong JK, Smith TN, Pitcher HT, Hirose H, Cavarocchi NC. Cerebral and lower limb near-infrared spectroscopy in adults on extracorporeal membrane oxygenation. Artif Organs. 2012;36:659–667.
119. Ostadal P, Kruger A, Vondrakova D, Janotka M, Psotova H, Neuzil P. Noninvasive assessment of hemodynamic variables using near-infrared spectroscopy in patients experiencing cardiogenic shock and individuals undergoing venoarterial extracorporeal membrane oxygenation. J Crit Care. 2014;29:690.e11–690.e15.
120. Wood MD, Maslove DM, Muscedere JG, Day AG, Gordon Boyd J. Cerebral Oxygenation and Neurological Outcomes Following Critical Illness Research Group; Canadian Critical Care Trials Group;Low brain tissue oxygenation contributes to the development of delirium in critically ill patients: a prospective observational study. J Crit Care. 2017;41:289–295.
121. Cournoyer A, Iseppon M, Chauny JM, Denault A, Cossette S, Notebaert É. Near-infrared spectroscopy monitoring during cardiac arrest: a systematic review and meta-analysis. Acad Emerg Med. 2016;23:851–862.
122. Deakin CD, Yang J, Nguyen R, et al. Effects of epinephrine on cerebral oxygenation during cardiopulmonary resuscitation: a prospective cohort study. Resuscitation. 2016;109:138–144.
123. Duvekot A, Viersen VA, Dekker SE. Low cerebral oxygenation levels during resuscitation in out-of-hospital cardiac arrest are associated with hyperfibrinolysis. Anesthesiology. 2015;123:820–829.
124. Genbrugge C, Eertmans W, Meex I. What is the value of regional cerebral saturation in post-cardiac arrest patients? A prospective observational study. Crit Care. 2016;20:327.
125. Genbrugge C, Meex I, Boer W. Increase in cerebral oxygenation during advanced life support in out-of-hospital patients is associated with return of spontaneous circulation. Crit Care. 2015;19:112.
126. Ibrahim AW, Trammell AR, Austin H. Cerebral oximetry as a real-time monitoring tool to assess quality of in-hospital cardiopulmonary resuscitation and post cardiac arrest care. J Am Heart Assoc. 2015;4:e001859.
127. Meex I, De Deyne C, Dens J. Feasibility of absolute cerebral tissue oxygen saturation during cardiopulmonary resuscitation. Crit Care. 2013;17:R36.
128. Nishiyama K, Ito N, Orita T. Characteristics of regional cerebral oxygen saturation levels in patients with out-of-hospital cardiac arrest with or without return of spontaneous circulation: a prospective observational multicentre study. Resuscitation. 2015;96:16–22.
129. Parnia S, Yang J, Nguyen R, et al. Cerebral oximetry during cardiac arrest: a multicenter study of neurologic outcomes and survival. Crit Care Med. 2016;44:1663–1674.
130. Singer AJ, Ahn A, Inigo-Santiago LA, Thode HC Jr, Henry MC, Parnia S. Cerebral oximetry levels during CPR are associated with return of spontaneous circulation following cardiac arrest: an observational study. Emerg Med J. 2015;32:353–356.
131. Wik L. Near-infrared spectroscopy during cardiopulmonary resuscitation and after restoration of spontaneous circulation: a valid technology? Curr Opin Crit Care. 2016;22:191–198.
132. Sanfilippo F, Serena G, Corredor C. Cerebral oximetry and return of spontaneous circulation after cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2015;94:67–72.
133. Zheng F, Sheinberg R, Yee MS, Ono M, Zheng Y, Hogue CW. Cerebral near-infrared spectroscopy monitoring and neurologic outcomes in adult cardiac surgery patients: a systematic review. Anesth Analg. 2013;116:663–676.
134. Goldman S, Sutter F, Ferdinand F, Trace C. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum. 2004;7:E376–E381.
135. Yao FS, Tseng CC, Ho CY, Levin SK, Illner P. Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18:552–558.
136. Slater JP, Guarino T, Stack J. Cerebral oxygen desaturation predicts cognitive decline and longer hospital stay after cardiac surgery. Ann Thorac Surg. 2009;87:36–44.
137. Murkin JM, Adams SJ, Novick RJ. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104:51–58.
138. Fischer GW, Lin HM, Krol M. Noninvasive cerebral oxygenation may predict outcome in patients undergoing aortic arch surgery. J Thorac Cardiovasc Surg. 2011;141:815–821.
139. de Tournay-Jetté E, Dupuis G, Bherer L, Deschamps A, Cartier R, Denault A. The relationship between cerebral oxygen saturation changes and postoperative cognitive dysfunction in elderly patients after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011;25:95–104.
140. Schoen J, Husemann L, Tiemeyer C. Cognitive function after sevoflurane- vs propofol-based anaesthesia for on-pump cardiac surgery: a randomized controlled trial. Br J Anaesth. 2011;106:840–850.
141. Palmbergen WA, van Sonderen A, Keyhan-Falsafi AM, Keunen RW, Wolterbeek R. Improved perioperative neurological monitoring of coronary artery bypass graft patients reduces the incidence of postoperative delirium: the Haga Brain Care Strategy. Interact Cardiovasc Thorac Surg. 2012;15:671–677.
142. Mohandas BS, Jagadeesh AM, Vikram SB. Impact of monitoring cerebral oxygen saturation on the outcome of patients undergoing open heart surgery. Ann Card Anaesth. 2013;16:102–106.
143. Colak Z, Borojevic M, Bogovic A, Ivancan V, Biocina B, Majeric-Kogler V. Influence of intraoperative cerebral oximetry monitoring on neurocognitive function after coronary artery bypass surgery: a randomized, prospective study. Eur J Cardiothorac Surg. 2015;47:447–454.
144. Kok WF, van Harten AE, Koene BM. A pilot study of cerebral tissue oxygenation and postoperative cognitive dysfunction among patients undergoing coronary artery bypass grafting randomised to surgery with or without cardiopulmonary bypass*. Anaesthesia. 2014;69:613–622.
145. Deschamps A, Hall R, Grocott H, et al. Canadian Perioperative Anesthesia Clinical Trials Group. Cerebral oximetry monitoring to maintain normal cerebral oxygen saturation during high-risk cardiac surgery: a randomized controlled feasibility trial. Anesthesiology. 2016;124:826–836.
146. Rogers CA, Stoica S, Ellis L. Randomized trial of near-infrared spectroscopy for personalized optimization of cerebral tissue oxygenation during cardiac surgery. Br J Anaesth. 2017;119:384–393.
147. Lei L, Katznelson R, Fedorko L. Cerebral oximetry and postoperative delirium after cardiac surgery: a randomised, controlled trial. Anaesthesia. 2017;72:1456–1466.
148. Casati A, Fanelli G, Pietropaoli P. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg. 2005;101:740–747.
149. Casati A, Fanelli G, Pietropaoli P, et al. Collaborative Italian Study Group on Anaesthesia in Elderly Patients. Monitoring cerebral oxygen saturation in elderly patients undergoing general abdominal surgery: a prospective cohort study. Eur J Anaesthesiol. 2007;24:59–65.
150. Lin R, Zhang F, Xue Q, Yu B. Accuracy of regional cerebral oxygen saturation in predicting postoperative cognitive dysfunction after total hip arthroplasty: regional cerebral oxygen saturation predicts POCD. J Arthroplasty. 2013;28:494–497.
151. Ni C, Xu T, Li N. Cerebral oxygen saturation after multiple perioperative influential factors predicts the occurrence of postoperative cognitive dysfunction. BMC Anesthesiol. 2015;15:156.
152. Kim J, Shim JK, Song JW, Kim EK, Kwak YL. Postoperative cognitive dysfunction and the change of regional cerebral oxygen saturation in elderly patients undergoing spinal surgery. Anesth Analg. 2016;123:436–444.
153. Tang L, Kazan R, Taddei R, Zaouter C, Cyr S, Hemmerling TM. Reduced cerebral oxygen saturation during thoracic surgery predicts early postoperative cognitive dysfunction. Br J Anaesth. 2012;108:623–629.
154. Serraino GF, Murphy GJ. Effects of cerebral near-infrared spectroscopy on the outcome of patients undergoing cardiac surgery: a systematic review of randomised trials. BMJ Open. 2017;7:e016613.
155. Davie SN, Grocott HP. Impact of extracranial contamination on regional cerebral oxygen saturation: a comparison of three cerebral oximetry technologies. Anesthesiology. 2012;116:834–840.
156. Greenberg S, Shear T, Murphy G. Extracranial contamination of near-infrared spectroscopy devices. Anesth Analg. 2017;124:356–358.
157. Greenberg S, Murphy G, Shear T. Extracranial contamination in the INVOS 5100C versus the FORE-SIGHT ELITE cerebral oximeter: a prospective observational crossover study in volunteers. Can J Anaesth. 2016;63:24–30.
158. Hirasawa A, Kaneko T, Tanaka N. Near-infrared spectroscopy determined cerebral oxygenation with eliminated skin blood flow in young males. J Clin Monit Comput. 2016;30:243–250.
159. Hirasawa A, Yanagisawa S, Tanaka N. Influence of skin blood flow and source-detector distance on near-infrared spectroscopy-determined cerebral oxygenation in humans. Clin Physiol Funct Imaging. 2015;35:237–244.
160. Kato S, Yoshitani K, Kubota Y, Inatomi Y, Ohnishi Y. Effect of posture and extracranial contamination on results of cerebral oximetry by near-infrared spectroscopy. J Anesth. 2017;31:103–110.
161. Ogoh S, Sato K, Okazaki K. A decrease in spatially resolved near-infrared spectroscopy-determined frontal lobe tissue oxygenation by phenylephrine reflects reduced skin blood flow. Anesth Analg. 2014;118:823–829.
162. Sørensen H, Secher NH, Siebenmann C. Cutaneous vasoconstriction affects near-infrared spectroscopy determined cerebral oxygen saturation during administration of norepinephrine. Anesthesiology. 2012;117:263–270.
163. Paarmann H, Heringlake M, Heinze H. Non-invasive cerebral oxygenation reflects mixed venous oxygen saturation during the varying haemodynamic conditions in patients undergoing transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2012;14:268–272.
164. Leyvi G, Bello R, Wasnick JD, Plestis K. Assessment of cerebral oxygen balance during deep hypothermic circulatory arrest by continuous jugular bulb venous saturation and near-infrared spectroscopy. J Cardiothorac Vasc Anesth. 2006;20:826–833.
165. Esnault P, Boret H, Montcriol A. Assessment of cerebral oxygenation in neurocritical care patients: comparison of a new four wavelengths forehead regional saturation in oxygen sensor (EQUANOX®) with brain tissue oxygenation. A prospective observational study. Minerva Anestesiol. 2015;81:876–884.
166. Scheeren TW, Saugel B. Journal of clinical monitoring and computing 2016 end of year summary: monitoring cerebral oxygenation and autoregulation. J Clin Monit Comput. 2017;31:241–246.
167. Joshi B, Ono M, Brown C. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg. 2012;114:503–510.
168. Ono M, Brady K, Easley RB. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg. 2014;147:483–489.
169. Hori D, Ono M, Rappold TE, et al. Hypotension after cardiac operations based on autoregulation monitoring leads to brain cellular injury. Ann Thorac Surg. 2015;100:487–493.
170. Moerman AT, Vanbiervliet VM, Van Wesemael A, Bouchez SM, Wouters PF, De Hert SG. Assessment of cerebral autoregulation patterns with near-infrared spectroscopy during pharmacological-induced pressure changes. Anesthesiology. 2015;123:327–335.
171. Rivera-Lara L, Zorrilla-Vaca A, Geocadin R, et al. Predictors of outcome with cerebral autoregulation monitoring: a systematic review and meta-analysis. Crit Care Med. 2017;45:695–704.